This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

TANGO2

Authoring team

TANGO2 (transport and Golgi organization 2 homolog)

  • was first identified in 2016 and encodes a protein that is postulated to be involved in redistributing the Golgi membranes into the endoplasmic reticulum (ER) (1,2)
  • TANGO2 itself is a protein-coding gene on chromosome 22 (22q11.21)
    • the function of the TANGO2 gene is still not clear (2)
      • data suggest multiple potential functions of the TANGO2 protein, including a role in the fusion of the Golgi apparatus with the endoplasmic reticulum, and mitochondrial structure and function

  • TANGO2 deficiency is hypothesised to induce dysfunction in lipid biosynthesis that is exacerbated under conditions that stress the body

  • is a rare, genetic, metabolic disorder characterized by (2):
    • developmental delay
    • gait incoordination
    • hypothyroidism
    • recurrent crises with associated metabolic derangements, myositis, rhabdomyolysis, and severe cardiac tachyarrhythmias

Presentation is often with a metabolic crisis precipitated by an infection or other catabolic state (1,2):

  • patients with TANGO2 deficiency generally have a history or current symptoms of psychomotor impairment characterized by ambulatory dysfunction and hypotonia as well as signs of neurodevelopmental decline
  • features of metabolic crises may consist of findings of rhabdomyolysis, seizures, ECG abnormalities including prolonged QT intervals and/or type I Brugada pattern, and severe arrhythmias including potentially life-threatening recalcitrant ventricular tachycardia
  • the diagnosis of TANGO2 deficiency should be considered in patients presenting in an acute metabolic crisis with life-threatening recalcitrant ventricular arrhythmias (2)
  • study evidence suggests (3):
    • development of hypothyroidism in 48% by age 4y
    • epilepsy occurs in 42% of individuals and is often drug-resistant
    • constipation occurs in 54%
    • speech delay/dysarthria 97%
    • development delay in the Majority of affected individuals 94% 
    • TANGO2 spells occur in 94% - generally consisting of ataxia/ head lag/ drooling/ strabismus

Management:

  • there is currently no cure
  • requires urgent involvement of metabolic team to support
  • research has shown huge benefits to B vitamins and it thought to be protective from over Crisis and improve access to energy due to its role in Coenzyme A production

Reference:

  1. Dines J et al. TANGO2: expanding the clinical phenotype and spectrum of pathogenic variants. Genet Med. 2019 Mar;21(3):601-607.
  2. Walters B, McConkey N, Imundo JR. TANGO2: A Rare but Important Mutation. J Innov Card Rhythm Manag. 2024 May 15;15(5):5871-5875.
  3. Miyake CY et al. Natural history of TANGO2 deficiency disorder: Baseline assessment of 73 patients. Genetics in Medicine (2023) 25, 100352

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.